MedTrace Logo

Neurodevelopment in Infants With Complex Congenital Heart Defects

NCT03104751 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2021-02-24

No results posted yet for this study

Summary

The primary goal of this study is to systematically describe early neurodevelopment using a complementary set of observational and neurophysiological measures that may predict cognitive and motor delays earlier than currently possible for infants with Complex Congenital Heart Disease (CCHD).

Conditions

  • Complex Congenital Heart Defect

Sponsors & Collaborators

  • American Heart Association

    collaborator OTHER

  • Nationwide Children's Hospital

    collaborator OTHER

  • Ohio State University

    lead OTHER

Principal Investigators

  • Jill Heathcock, MPT, PhD · Ohio State University

Eligibility

Min Age
1 Day
Max Age
30 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2018-10-24
Completion
2018-10-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03104751 on ClinicalTrials.gov